Mangalam Drugs & Organics Limited (NSE:MANGALAM)
India · Delayed Price · Currency is INR 27.42
-0.55 (-1.97%)
Jul 14, 2026, 3:29 PM IST
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 436.38 million as of July 14, 2026. Its market cap has decreased by -65.40% in one year.
Market Cap
436.38M
Enterprise Value
1.56B
Revenue
2.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
27.42
Market Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 436.38M, an increase of 103.57%. That is a compound annual growth rate of 3.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 436.38M | -0.07% |
| Dec 31, 2025 | 436.70M | -76.09% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 8.66B |
| Bafna Pharmaceuticals | 4.84B |
| Valiant Laboratories | 3.37B |
| Nectar Lifesciences | 2.17B |
| Brooks Laboratories | 2.07B |
| Alpa Laboratories | 1.44B |
| Balaxi Pharmaceuticals | 1.33B |
| Par Drugs and Chemicals | 1.10B |